The Artificial Intelligence (AI) In Drug Discovery Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of artificial intelligence in drug discovery has seen exponential growth recently. The market, valued at $1.78 billion in 2024, is projected to rise to $2.34 billion in 2025, reflecting a compound annual growth rate (CAGR) of 31.1%.
The artificial intelligence (AI) in drug discovery market is projected to reach $5.98 billion in 2029, with a compound annual growth rate (CAGR) of 26.5%.
Download Your Free Sample of the 2025 Artificial Intelligence (AI) In Drug Discovery Market Report and Uncover Key Trends Now!The key drivers in the artificial intelligence (ai) in drug discovery market are:
• Government support in research and development in AI for drug discovery
• Increasing healthcare expenditure worldwide
• Rising adoption of cloud-based applications and services in drug discovery
• Growth in investments on partnerships and collaborations in AI drug discovery sector
The artificial intelligence (AI) in drug discovery market covered in this report is segmented –
1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning
2) By Drug Type: Small Molecules, Large Molecules
3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics
4) By End User: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users
The key trends in the artificial intelligence (ai) in drug discovery market are:
• The integration of multi-omics data is a significant emerging trend.
• AI's application in target choice for drug discovery is becoming prevalent.
• AI's usage in drug screening procedures is on the rise.
• The establishment of AI innovation labs and an increase in partnerships and collaborations investments are trending.
Major companies in the artificial intelligence (ai) in drug discovery market are:
• IBM Corporation
• Microsoft Corporation
• NVIDIA Corporation
• Exscientia
• Alphabet
• Insilico Medicine
• Owkin Inc
• Xtalpi Inc
• Cloud Pharmaceuticals
• Shanghai PharmaceuticS
• Standigm
• Indegene
• Intuition Systems
• Innoplexus
• Takeda Pharmaceutical Company Ltd.
• RxPrism
• Otsuka Pharmaceutical Co. Ltd.
• China National Pharmaceutical Group Co., Ltd.
• Jiangsu Hengrui Medicine Co., Ltd
• Cipla Limited
• Aurobindo Pharma Limited
• Dr. Reddy’s Laboratories Ltd.
• Sun Pharma
• Tricog Health Services Pvt. Ltd.
• Alliance Pharm Pte Ltd.
• CytoReason
• IIPharma
• StoneWise
• Adagene
• GT Apeiron Therapeutics
• Xbiome
• Accutar Biotech
• DeepMind
• Renalytix AI
• Iktos
• Ipsen Pharma
• Galderma S.A.
• BenevolentAI
• Deepflare
• Novartis
• Gero
• Ardigen
• Botkin
• Care Mentor AI
• Diagnocat
• GNS Healthcare
• Merck & Co.
• Apotex
• Pfizer
• Gilead Sciences
• Roche
• Bayer
• AbbVie Inc.
• GlaxoSmithKline
• AstraZeneca
• Amgen
• Sanofi Pasteur
• Abbott Laboratories
• Teva Canada
• Accord Healthcare Inc
• Acerus Pharmaceuticals Corporation
• AA Pharma Inc
• Sanfer
• Siegfried Rhein
• Atomwise, Inc.
• Bioage
• NuMedii
• Envisagenics
• Aria Pharmaceuticals
• Verge Genomics
• Berg LLC
• Deep Genomics
• Cyclica
• IQVIA
• Quris
• GE Healthcare
• Avanade
• Group42 Holding Ltd
• Ilara Health
• Adcock Ingram
• Johnson & Johnson
• Eurolab
• Ranbaxy (SA) (Pty) Ltd
• Aspen
• Rology
• hearX Group
• DilenyTech
North America was the largest region in the artificial intelligence (AI) in drug discovery market in 2024